Trikafta 60 mg

Trikafta 60 MG granules contain ivacaftor, a medication used to treat cystic fibrosis. This oral formulation is designed for patients who require a specific dosage strength.

Trikafta 60 MG granules are primarily used in the management of cystic fibrosis. Ivacaftor, the active ingredient, works to improve the function of a protein affected by the genetic condition. This medication is often prescribed as part of a comprehensive treatment plan to help manage symptoms and improve quality of life for individuals with cystic fibrosis.

Common effects of Trikafta 60 MG granules may include improvements in lung function and overall health for individuals with cystic fibrosis. Some users may experience side effects such as headache, stomach pain, or dizziness. It is important to consult with a healthcare provider to understand potential effects and monitor progress.

Trikafta 60 MG granules should be handled with care and stored as directed. It is essential to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should be aware of any allergies or sensitivities to the ingredients in the medication.

Trikafta 60 MG granules may interact with certain medications, including those that are metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect the efficacy of ivacaftor.